YY/T 1713-2020Diagnostic kit for colloidal gold immunochromatographic assay (English PDF)
胶体金免疫层析法检测试剂盒
This is a limited preview
Buy now to download the full PDF (26 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1713-2020 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
September 27, 2020
Implementation date
June 1, 2022
Scope
YY/T 1713-2020 is the English-translated version of 胶体金免疫层析法检测试剂盒.
YY/T 1713-2020 is the Chinese pharmaceutical industry standard for diagnostic kits that work by colloidal gold immunochromatography, the lateral flow strips read by eye.
It gives the terms and definitions, the requirements, the test methods, the labels and instructions for use and the rules for packaging, transport and storage, covering the appearance of the strip and the migration of the sample, the agreement with reference materials at and around the cut-off, the specificity, the repeatability between strips and lots and the stability. Issued on 27 September 2020, it has applied since 1 June 2022.
Found what you need?
Document preview — YY/T 1713-2020
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Terms and definitions4
- 4 Requirements7
- 5 Test methods18
- 6 Labels and instructions for use24
- 7 Packaging, transportation and storage25
- Bibliography26
Foreword
This Standard was drafted in accordance with the rules given in GB/T 1.1-2009.
1 Scope
This Standard specifies relevant terms and definitions, requirements, test methods, labels and instructions for use, packaging, transportation and storage of diagnostic kit for colloidal gold immunochromatographic assay.
This Standard is applicable to diagnostic kit that uses the colloidal gold immunochromatographic assay as the principle to conduct quantitative, semiquantitative, qualitative examinations to human sample (blood, urine, feces, saliva and so on).
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.
GB/T 21415, In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
GB/T 29791.2, In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1 Qualitative examination
a set of operations that identify or classify substances based on their chemical or physical properties
3.2 Semiquantitative examination
essentially, it is a qualitative test that adds options for the degree of response (positive degree, dilution to obtain a positive result, or comparison with the color card); the reaction results can be presented using ordinal tables and so on Example. The examination result can be reported as "-" "±" "+" "++".
3.3 Quantitative examination a set of operations that measure
the amount or concentration of an analyte and express it in a digital value of the appropriate measurement unit [GB/T 29791.1-2013, definition A.3.45]
3.5 C5-c95 interval
the concentration range of the analyte near the cutoff can be considered that more than 95% of the examination results of the analyte outside this concentration range are negative (concentration< c5) or more than 95% are positive (concentration >c95)
3.6 Limit of detection
the measured value obtained from a given measurement program; for this value, given that the false positive probability of a certain component in the claimed substance is alpha, the false positive probability of the non-existent component is beta
3.8 Analytical specificity
the ability of the examination procedure to only examine or measure the presence of the measurand when there are other quantities in the sample [GB/T 29791.1-2013, definition A.2.6]
4 Requirements
4.1 Diagnostic kit for qualitative examination
4.1.1 Appearance
Meet the normal appearance requirements specified by the manufacturer.
4.1.2 Net content (when applicable)
If the kit contains liquid components, the volume shall meet the following requirements.
4.1.3 Film strip width
The manufacturer shall specify the width of the film strip (lower limit or deviation).
The random test shall be no less than the manufacturer's claim.
4.1.6 Compliance rate of negative reference products (when applicable)
Separately examine different reference products/samples used to evaluate the negative coincidence rate of reagents once each. The examination results shall all be negative.
4.1.8 Analytical specificity (when applicable)
Examine the negative reference product/sample containing a certain concentration/level of cross-reactant 3 times. The examination result shall not be positive.
4.1.9 High dose hook effect (when applicable)
Examine the high concentration/level positive reference product/sample claimed by the manufacturer 3 times. There shall be no false negatives in the examination results.
4.1.10 Repeatability
Test the negative and weakly positive reference products/samples with the indicated concentration/level at least 10 times. The coincidence rate of negative and positive results shall not be less than 95%.
The repeatability concentration/level setting and result judgment shall follow the following principles.
4.2.6 Analytical specificity (when applicable)
Examine the negative reference product/sample containing a certain concentration/level of cross-reactant 3 times. The result shall not be positive.
4.2.7 High dose hook effect (when applicable)
Examine the high concentration/level positive reference product/sample claimed by the manufacturer 3 times. The result shall be no false negatives.
4.3 Diagnostic kit for quantitative examination
4.3.1 Appearance
Meet the normal appearance requirements specified by the manufacturer.
4.3.6 Accuracy
It can use one of the following methods to verify. The relative deviation method is preferred.
5 Test methods
5.1 Diagnostic kit for qualitative examination
5.1.1 Appearance
Visually inspect with normal vision or corrected vision under natural light, which shall be in accordance with the requirements in 4.1.1.
5.1.5 Limit of detection
Respectively examine the reference product/sample of different gradients with the indicated concentration/level once each. The result shall meet the requirements of 4.1.5.
5.1.6 Negative coincidence rate (when applicable)
Respectively examine different reference products/samples used to evaluate the specificity of reagents once each. The result shall meet the requirements of 4.1.6.
5.1.7 Positive coincidence rate (when applicable)
Respectively examine different reference products/samples used to evaluate the sensitivity of reagents once each. The result shall meet the requirements of 4.1.7.
5.1.10 Repeatability
Examine the negative and weakly positive reference products/samples with the indicated concentration/level at least 10 times. The result shall meet the requirements of 4.1.10.
5.1.11 Batch-to-batch difference
Extract 3 batches of kits. Respectively examine each batch of weakly positive reference products/samples with indicated concentrations/levels at least 10 times. The result shall meet the requirements of 4.1.11.
5.2 Diagnostic kit for semiquantitative examination
5.2.1 Appearance
Visually inspect with normal vision or corrected vision under natural light, which shall meet the requirements in 4.1.1.
5.2.2 Net content (when applicable)
Use a universal measuring tool to measure the number of liquid reagents, which shall meet the requirements in 4.2.2.
5.2.8 Repeatability
Respectively examine the concentration/level of different levels of concentration reference products/samples at least 10 times each. The result shall meet the requirements of 4.2.8.
5.2.9 Batch-to-batch difference
Extract 3 batches of kits. Each batch shall be tested respectively at least 10 times for the reference product/sample with the indicated concentration/level. The result shall meet the requirements of 4.2.9.
5.2.10 Stability
5.2.10.1 Stability of validity period
The diagnostic kit is stored under the specified storage conditions until the end of the validity period. Examine according to 5.2.5, 5.2.6, 5.2.7, 5.2.8. The result shall meet the requirements of 4.2.10a).
5.3.8 Linear
Dilute high-value samples close to the upper limit of the linear interval to at least
5 Concentrations in
a certain proportion, where the samples with low concentration must be close to the lower limit of the linear interval.
5.3.12 Stability
5.3.12.1 Stability of validity period
The diagnostic kit is stored under the specified storage conditions until the end of the validity period. Examine according to 5.3.6, 5.3.7, 5.3.8, 5.3.9, 5.3.10. The result shall meet the requirements of 4.3.12a).
6 Labels and instructions for use
Shall meet the requirements of GB/T 29791.2.
7 Packaging, transportation and storage
7.1 Packaging
The packaging shall meet the following requirements.
7.2 Transportation
Transport in accordance with the conditions stipulated in the contract.
7.3 Storage
Store in accordance with the conditions specified by the manufacturer.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 26 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 21415In vitro diagnostic medical devices - Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples
- GB/T 29791.2In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
Similar standards
How to Download YY/T 1713-2020
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 21415-2008 — In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
GB/T 21415-2025 — In vitro diagnostic medical devices - Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
Secure payment via Stripe
Payments accepted
YY/T 1713-2020
$240.00